References
- Beck T M, York M, Chang A, , The S3A-376 Study Group, et al. Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. Cancer Invest 1997; 15: 297–303